{
  "meta": {
    "title": "71_Dvt_And_Pulmonary_Embolism",
    "url": "https://brainandscalpel.vercel.app/71-dvt-and-pulmonary-embolism-cf103587.html",
    "scrapedAt": "2025-11-30T12:29:02.259Z"
  },
  "questions": [
    {
      "text": "A patient was brought to the emergency with complaints of chest pain, hemoptysis, and severe dyspnea. CT scan showed vessel sign suggestive of pulmonary infarction. Which among the following is typically responsible for this?",
      "choices": [
        {
          "id": 1,
          "text": "Small pulmonary embolism"
        },
        {
          "id": 2,
          "text": "Submassive pulmonary embolism"
        },
        {
          "id": 3,
          "text": "Massive pulmonary embolism"
        },
        {
          "id": 4,
          "text": "Saddle embolism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Pulmonary infarction as suggested by CT is typically due to a <strong>small pulmonary embolism.</strong></p>\n<p>Pulmonary infarction occurs when <strong>small thrombi</strong> lodge in the <strong>segmental</strong> and <strong>subsegmental vessels</strong>. These patients most often have <strong>pleuritic chest pain</strong>&nbsp;as the site where the thrombus lodges are near the innervation of pleural nerves.</p>\n<p><strong>Massive pulmonary emboli</strong> and <strong>saddle emboli</strong> that occlude the main pulmonary artery cause&nbsp;<strong>hypotension</strong> and <strong>shock</strong> as opposed to infarction. These are caused by&nbsp;<strong>l</strong><strong>arger-sized emboli</strong> that lodge more proximally in the pulmonary circulation.</p>\n<p>Pulmonary embolism is classified based on the degree of reduction of pulmonary vascular blood flow and associated hemodynamic disturbances:&nbsp;</p>\n<ul>\n<li aria-level=\"1\"><strong>Massive</strong>: Hypotension lasting for &gt;15 minutes or BP maintained with inotropes.</li>\n<li aria-level=\"1\"><strong>Submassive</strong>: No hypotension, but features of cardiac injury present.</li>\n<li aria-level=\"1\"><strong>Non-massive</strong>: No hypotension or features of cardiac injury.&nbsp;</li>\n</ul>\n<p>CT findings associated with pulmonary infarction include a <strong>feeding vessel</strong> or <strong>vessel sign</strong> as shown below. It depicts a distinct vessel feeding directly to a lesion, usually of hematogenous origin. However, it is not specific for pulmonary infarction.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aebc617bd39743029953f67c33f9c404x1280x1278.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1873",
      "difficulty": "hard"
    },
    {
      "text": "A patient with a suspected pulmonary embolism underwent a chest X-ray. It showed an enlarged right descending pulmonary artery.  What is this sign called?",
      "choices": [
        {
          "id": 1,
          "text": "Westermark’s sign"
        },
        {
          "id": 2,
          "text": "Hampton’s hump"
        },
        {
          "id": 3,
          "text": "Palla’s sign"
        },
        {
          "id": 4,
          "text": "Black pleura sign"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Enlarged right descending pulmonary artery on a chest X-ray in pulmonary embolism is called <strong>Palla&rsquo;s sign.</strong></p>\n<p>The&nbsp;<strong>black pleura </strong>sign is seen in alveolar pulmonary microlithiasis. It refers to the shadow of the pleura between the extensive alveolar calcification and the adjacent rib cage.</p><hr><h3>Related Pearl: Chest X Ray signs in pulmonary embolism</h3><p><strong>Westermark's sign:&nbsp;</strong>Focal area of oligemia (decreased vascular markings) distal to the embolism.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1320503c26a8431b903e7e15089c8ed4x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Hampton's hump:&nbsp;</strong>Peripherally placed wedge-shaped or dome-shaped opacity due to infarction of lung tissue.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5faac4b6986f4b6da649d4ca027f99b3x1063x874.JPEG\" alt=\"Pearl Image\"><p><strong>Palla's sign:&nbsp;</strong>Increased size of the right descending pulmonary artery with a sausage-like appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d6849e258104848bfc976a72abaae15x1069x804.JPEG\" alt=\"Pearl Image\"><p><strong>Fleishner sign</strong>: enlarged pulmonary artery.</p>\n<p><strong>Melting sign</strong>:&nbsp;an infarct shows rapid clearing in contrast to pneumonic consolidation.</p>\n<p><strong>McConnell's</strong>&nbsp;<strong>sign</strong> (indirect sign of PE seen in transthoracic echo):&nbsp;<strong>hypokinesis</strong>&nbsp;of the right ventricular free wall with&nbsp;<strong>normal motion</strong>&nbsp;of the right ventricle apex.</p>\n<p><strong>Knuckle&nbsp;</strong>or<strong>&nbsp;sausage&rsquo; sign:&nbsp;</strong>dilatation of the pulmonary artery,&nbsp;proximal to the embolus with collapse or constriction of the distal arteries resulting in an abrupt tapering of these arteries. &nbsp;</p>\n<p>Note - A normal chest X-ray does not rule out pulmonary embolism in a patient with unexplained acute tachypnea or hypoxemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7326",
      "difficulty": "medium"
    },
    {
      "text": "Echocardiography in a patient with pulmonary embolism revealed akinesia of the right ventricular free wall with normal motion at the right ventricular apex. What is this sign called?",
      "choices": [
        {
          "id": 1,
          "text": "Moses’ sign"
        },
        {
          "id": 2,
          "text": "McConnell’s sign"
        },
        {
          "id": 3,
          "text": "Homan’s sign"
        },
        {
          "id": 4,
          "text": "Lowenberg’s sign"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The sign described is called <strong>McConnell&rsquo;s sign.</strong></p>\n<p>It demonstrates <strong>right</strong> <strong>ventricular dysfunction</strong> as&nbsp;akinesia of the right ventricular free wall with normal motion at the right ventricular apex.&nbsp;It<strong>&nbsp;</strong>is the best-known <strong>indirect</strong> sign of <strong>pulmonary embolism</strong> on transthoracic echocardiography.&nbsp;<strong><br /></strong></p>\n<p>Moses' (Bancroft's), Homan&rsquo;s, and&nbsp;Lowenberg&rsquo;s signs are seen in venous thrombosis. They're not specific to pulmonary embolism.</p><hr><h3>Related Pearl: Signs related to venous thrombosis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sign</strong></p>\n</td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>\n<p>Moses&rsquo;</p>\n<p>sign&nbsp;</p>\n</td>\n<td>Clinical&nbsp;sign found in patients with deep vein thrombosis of the lower leg involving the posterior&nbsp;tibial&nbsp;veins. The sign is positive if pain is elicited when the calf muscle is compressed forwards against the tibia, but not when the calf muscle is compressed from side to side.&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Homan&rsquo;s</p>\n<p>sign&nbsp;&nbsp;</p>\n</td>\n<td>Another clinical sign found in patients with deep vein thrombosis. It is the&nbsp;discomfort behind the knee on forced dorsiflexion of the foot.</td>\n</tr>\n<tr>\n<td>\n<p>Lowenberg&rsquo;s</p>\n<p>sign&nbsp;</p>\n</td>\n<td>Clinical&nbsp;sign found in patients with deep vein thrombosis of the lower leg. The sign is positive when pain is elicited rapidly when a blood pressure cuff is placed around the calf and inflated to 80 mmHg.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7341",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following biomarker is least likely to be elevated in a patient with pulmonary embolism?",
      "choices": [
        {
          "id": 1,
          "text": "Troponins"
        },
        {
          "id": 2,
          "text": "BNP"
        },
        {
          "id": 3,
          "text": "Heart-type fatty acid–binding protein"
        },
        {
          "id": 4,
          "text": "NGAL"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>NGAL&nbsp;</strong>(Neutrophil gelatinase-associated lipocalin)&nbsp;is a <strong>kidney injury marker</strong> and not a cardiac injury marker.</p>\n<p>The following are biomarkers of cardiac injury in pulmonary embolism:</p>\n<ul>\n<li>Plasma brain natriuretic peptide (BNP)</li>\n<li>Heart-type fatty acid binding protein</li>\n<li>Troponins.</li>\n</ul>\n<p>Serum troponin and plasma heart-type fatty acid-binding protein levels increase because of right ventricular <strong>microinfarction</strong>. <strong>Myocardial stretch</strong> causes the release of brain natriuretic peptide (BNP) or NT-proBNP.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7358",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions is likely to show increased D-dimer values?<div class='question-desc-html'><p>1.&nbsp;Myocardial infarction</p>\n<p>2.&nbsp;Pneumonia</p>\n<p>3.&nbsp;Pregnancy</p>\n<p>4. Sepsis</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2"
        },
        {
          "id": 2,
          "text": "1,3,4"
        },
        {
          "id": 3,
          "text": "2,3"
        },
        {
          "id": 4,
          "text": "1,2,3,4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>All of the conditions mentioned above have raised D-dimer levels.</p>\n<p>D-dimer is a <strong>fibrin</strong> <strong>degradation</strong> product.</p>\n<p>Plasma D-dimer levels commonly rise in <strong>DVT</strong> and <strong>pulmonary</strong> <strong>embolism</strong> due to the breakdown of fibrin by plasmin. D-dimer is more sensitive to pulmonary embolism than DVT. The <strong>sensitivity</strong> of D-dimer levels in the diagnosis of<strong> pulmonary embolism </strong>is &gt;<strong> 95%&nbsp;</strong>but it is&nbsp;is <strong>not specific</strong> for pulmonary embolism.</p>\n<p>Normal D-dimer rules out pulmonary embolism in low and intermediate-risk patients. Patients with a high risk of PE should undergo a CT pulmonary angiogram to effectively rule out PE.</p>\n<p>Conditions which have raised D-dimer levels include:</p>\n<ul>\n<li>Myocardial infarction</li>\n<li>Pneumonia</li>\n<li>Sepsis</li>\n<li>Cancer</li>\n<li>Postoperative state</li>\n<li>Pregnancy- second and third trimester</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1879",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged patient presents to the emergency department with a sudden onset pain in the right leg. The pain is associated with swelling, redness, and tenderness. Which of the following is false regarding the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Recurrence of this condition despite intensive anticoagulation is an indication for IVC filter"
        },
        {
          "id": 2,
          "text": "IVC filters can prevent recurrent PE in patients of right heart failure"
        },
        {
          "id": 3,
          "text": "IVC filters reduce the rate of recurrence of this condition"
        },
        {
          "id": 4,
          "text": "Pulmonary thromboendarterectomy is done in patients with chronic thromboembolic pulmonary hypertension"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above scenario is suggestive of deep vein thrombosis <strong>(DVT)</strong>. IVC filters <strong>increase </strong>the rate of<strong> recurrence </strong>of DVT (by providing a nidus for clot formation) even though they usually prevent pulmonary embolism (over the short term).</p>\n<p>The two <strong>principal</strong> <strong>indications</strong> for insertion of an <strong>IVC</strong> <strong>filter</strong> are:</p>\n<ol>\n<li>Active bleeding (prevents the use of anticoagulation)</li>\n<li>Recurrent venous thrombosis despite intensive anticoagulation</li>\n</ol>\n<p>Prevention of recurrent PE in patients with right heart failure who are not candidates for fibrinolysis and prophylaxis of extremely high-risk patients are some other indications for filter placement.</p>\n<p>Patients impaired by dyspnea due to chronic thromboembolic pulmonary hypertension should be considered for pulmonary thromboendarterectomy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7313",
      "difficulty": "medium"
    },
    {
      "text": "A resident is evaluating a patient, who presented with acute onset of chest pain and dyspnea, for pulmonary embolism. Which of the following imaging test should be performed to confirm this diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Doppler echocardiography"
        },
        {
          "id": 2,
          "text": "CT pulmonary angiography"
        },
        {
          "id": 3,
          "text": "Ventilation perfusion scan of lungs"
        },
        {
          "id": 4,
          "text": "MR pulmonary angiography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>CT pulmonary angiography</strong>&nbsp;should be performed as it is the <strong>principal</strong> imaging test for the <strong>diagnosis</strong> of pulmonary embolism (PE).</p>\n<p>Option A: Most patients with acute PE have <strong>normal</strong> <strong>echocardiograms</strong>. However, echocardiography is a very useful <strong>diagnostic tool</strong> for detecting conditions that may <strong>mimic PE</strong>, such as acute myocardial infarction, pericardial tamponade, and aortic dissection.</p>\n<p>Option C: <strong>Ventilation-perfusion</strong> (V/Q) scanning has become a <strong>second-line</strong> diagnostic test for PE, used mostly for patients who cannot tolerate intravenous contrast or in whom the CT results are inconclusive.</p>\n<p>Option D: <strong>MR pulmonary angiography</strong> may detect large proximal PE but is <strong>not reliable</strong> for smaller segmental and subsegmental PE. It is used when neither CT angiography nor ventilation-perfusion scan can be done.&nbsp;</p>\n<p>The images below demonstrate a pulmonary embolus (marked by arrows). The image of the gross specimen shows <strong>saddle thromboembolism.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3deedeebeb6c408483be4651e755d530x1072x831.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/faa4e0ce5d3c4987a19a999a4fa1ec57x800x570.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3dccaa20c5184acdbff5d98c7db3369dx800x542.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7330",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old patient is diagnosed with deep vein thrombosis in his right limb. Which of the following parameters is a part of Well’s criteria that assess the clinical likelihood of pulmonary embolism in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Dyspnea"
        },
        {
          "id": 2,
          "text": "Orthopnea"
        },
        {
          "id": 3,
          "text": "Chest pain"
        },
        {
          "id": 4,
          "text": "Hemoptysis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hemoptysis</strong> is a parameter in <strong>Well&rsquo;s criteria</strong> used to assess the likelihood of<strong> pulmonary embolism</strong>.</p><hr><h3>Related Pearl: Clinical prediction for pulmonary embolism: Well’s, Modified Well’s and Pulmonary Embolism Rule out Criteria (PERC)</h3><table>\n<tbody>\n<tr>\n<td><strong>Signs/symptoms</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Clinical signs of DVT</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Diagnosis other than pulmonary embolism is less likely</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Heart rate &gt;100 bpm</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Immobilization for &gt;3 days or surgery in the last 4 weeks</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Past history of DVT/pulmonary embolism</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Hemoptysis</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Malignancy</td>\n<td>1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Three-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>&lt;2</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>2-6</td>\n</tr>\n<tr>\n<td>High</td>\n<td>&gt;6</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Two-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Modified Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Pulmonary embolism unlikely</td>\n<td>&le;4</td>\n</tr>\n<tr>\n<td>Pulmonary embolism likely</td>\n<td>&gt;4&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>&nbsp;</p>\n<p><strong>Pulmonary embolism rule out criteria (PERC):</strong></p>\n<p>This is a quick OPD/casualty tool to rule out pulmonary embolism in patients with low clinical probability. It comprises <strong>eight clinical variables</strong>. If the patient meets all eight criteria, there is no need for further investigations. The variables include:&nbsp;</p>\n<ol>\n<li aria-level=\"1\">Age &lt;50 years</li>\n<li aria-level=\"1\">Heart rate &lt;100 bpm</li>\n<li aria-level=\"1\">SpO2 &ge;95%</li>\n<li aria-level=\"1\">No unilateral leg swelling</li>\n<li aria-level=\"1\">No hemoptysis</li>\n<li aria-level=\"1\">No recent trauma or surgery</li>\n<li aria-level=\"1\">No history of venous thromboembolism</li>\n<li aria-level=\"1\">No use of hormonal therapy.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7346",
      "difficulty": "hard"
    },
    {
      "text": "In a patient with a Well's score of 1.5, which of the following should be the initial investigation?",
      "choices": [
        {
          "id": 1,
          "text": "D-dimer levels"
        },
        {
          "id": 2,
          "text": "CT pulmonary angiography"
        },
        {
          "id": 3,
          "text": "V/Q lung scan"
        },
        {
          "id": 4,
          "text": "Doppler ultrasonography"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A patient with Well's score of 1.5 has a&nbsp;<strong>low probability </strong>of pulmonary embolism. The <strong>initial investigation</strong> should be the measurement of <strong>D-dimer </strong>levels<strong>.</strong></p>\n<p>In a patient with<strong>&nbsp;</strong>a<strong> high probability </strong>of pulmonary embolism,&nbsp;the initial investigation is<strong> CT pulmonary angiography.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/27f85ad8831c4dd4ad111da9dd5b274ex1280x1408.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1904",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an indication for fibrinolytic therapy in a patient diagnosed with massive pulmonary embolism?",
      "choices": [
        {
          "id": 1,
          "text": "Persistent hypotension"
        },
        {
          "id": 2,
          "text": "RV dysfunction"
        },
        {
          "id": 3,
          "text": "RV enlargement on chest CT"
        },
        {
          "id": 4,
          "text": "Benign intracranial neoplasm"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>For <strong>fibrinolysis</strong>&nbsp;(thrombolytic therapy) in massive pulmonary embolism, the only widely accepted indication is <strong>persistent hypotension</strong> or<strong> shock</strong>.&nbsp;It is&nbsp;defined as SBP &lt;90mmHg or a decrease in SBP by <span class=\"Y0NH2b CLPzrc\">&ge;</span>40 mmHg from baseline for &gt;15 minutes.</p>\n<p><strong>Alteplase</strong> or recombinant tissue plasminogen activator (tPA),<strong> streptokinase, </strong>and<strong> urokinase</strong> are approved for the treatment of PE. tPA is the most commonly used fibrinolytic, but it is not superior to other agents.</p>\n<p>Pulmonary embolism is classified based on the degree of reduction of pulmonary vascular blood flow and associated hemodynamic disturbances:&nbsp;</p>\n<ul>\n<li aria-level=\"1\"><strong>Massive</strong>: Hypotension lasting for &gt;15 minutes or BP maintained with inotropes.</li>\n<li aria-level=\"1\"><strong>Submassive</strong>: No hypotension, but features of cardiac injury present.</li>\n<li aria-level=\"1\"><strong>Non-massive</strong>: No hypotension or features of cardiac injury.</li>\n</ul>\n<p><strong>Contraindications for thrombolysis:</strong></p>\n<ul>\n<li>Haemorrhagic stroke</li>\n<li>Ischemic stroke in the last 6 months</li>\n<li>CNS tumours</li>\n<li>Major surgery/trauma in the last 3 weeks</li>\n<li>Active bleeding</li>\n<li>Bleeding diathesis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7303",
      "difficulty": "hard"
    },
    {
      "text": "A 32-year-old woman with SLE, secondary anti-phospholipid antibody syndrome develops pulmonary embolism. After admission, she is started on anticoagulants. For how long should the anticoagulation therapy be continued?",
      "choices": [
        {
          "id": 1,
          "text": "12-24 months"
        },
        {
          "id": 2,
          "text": "3-5 years"
        },
        {
          "id": 3,
          "text": "6-12 months"
        },
        {
          "id": 4,
          "text": "Indefinitely"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Duration</strong> of anticoagulation for DVT and venous thromboembolism <strong>secondary</strong> to antiphospholipid antibody syndrome <strong>(APLA)</strong> is <strong>lifelong.</strong></p>\n<p>Duration of anticoagulation for DVT and venous thromboembolism:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical Scenario</strong></td>\n<td><strong>Duration of Anticoagulation</strong></td>\n</tr>\n<tr>\n<td>DVT isolated to an upper extremity or calf that has been provoked by surgery, trauma, estrogen, or an indwelling central venous catheter or pacemaker</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Provoked proximal leg DVT or PE</td>\n<td>3 to 6 months</td>\n</tr>\n<tr>\n<td>For patients with cancer and VTE</td>\n<td>\n<p>Prescribe LMW heparin</p>\n<p>Continue anticoagulation indefinitely unless the patient is rendered cancer-free</p>\n</td>\n</tr>\n<tr>\n<td>Idiopathic unprovoked VTE</td>\n<td>Indefinite</td>\n</tr>\n<tr>\n<td>Antiphospholipid antibody syndrome</td>\n<td>Indefinite</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7310",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drug was recently approved by FDA for the extended prophylaxis of venous thromboembolism in hospitalized medically ill patients?",
      "choices": [
        {
          "id": 1,
          "text": "Unfractionated heparin"
        },
        {
          "id": 2,
          "text": "Apixaban"
        },
        {
          "id": 3,
          "text": "Enoxaparin"
        },
        {
          "id": 4,
          "text": "Betrixaban"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Betrixaban </strong>is a new oral, once-daily factor <strong>Xa inhibitor</strong> approved by the United States Food and Drug Administration<strong> (FDA)</strong> for extended-duration<strong> prophylaxis of VTE </strong>in acute medically ill patients.</p>\n<p>In patients with no obvious risk factors for VTE, <strong>early ambulation</strong> with or without mechanical methods (pneumatic compression stockings or venous foot pump) should be advised.</p>\n<p>In patients with one risk factor for VTE with no risk of bleeding, <strong>LMWH</strong> is preferred.&nbsp;In presence of renal failure/cost issues,&nbsp;<strong>unfractionated heparin&nbsp;</strong>is used. In the case of heparin-induced thrombocytopenia,&nbsp;<strong>fondaparinux&nbsp;</strong>is preferred.</p>\n<p>In patients with multiple risk factors, increasing the dose of <strong>anticoagulants</strong> or using a mechanical device is advised. For patients with risk factors and a high risk of bleeding or contraindication for anticoagulation, <strong>mechanical methods</strong> are recommended.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7315",
      "difficulty": "hard"
    },
    {
      "text": "What is May-Thurner syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Compression of right iliac vein by right iliac artery"
        },
        {
          "id": 2,
          "text": "Compression of right iliac vein by left iliac artery"
        },
        {
          "id": 3,
          "text": "Compression of left iliac vein by right iliac artery"
        },
        {
          "id": 4,
          "text": "Compression of left iliac vein by left iliac artery"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>May-Thurner syndrome (MTS) is&nbsp;caused when the<strong> left iliac vein </strong>is<strong> compressed by </strong>the<strong> right iliac artery&nbsp;</strong>against the fifth lumbar vertebra.&nbsp;It is also called iliocaval venous compression syndrome, iliac vein compression syndrome, Cockett's syndrome, and venous spur.</p>\n<p>Most patients have a partial obstruction and are asymptomatic. It can however progress to symptomatic extensive deep vein thrombosis (DVT). It is a cause of <strong>recurrent DVT</strong> affecting the left leg.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7342",
      "difficulty": "medium"
    },
    {
      "text": "You are evaluating a patient with a cardio-respiratory compromise. Chest X-ray shows a focal area of oligemia. The ECG of the patient is shown below. Choose the false statement regarding this condition.",
      "choices": [
        {
          "id": 1,
          "text": "Most common symptom is dyspnea"
        },
        {
          "id": 2,
          "text": "Most common sign is tachycardia"
        },
        {
          "id": 3,
          "text": "Most common ECG abnormality is sinus tachycardia"
        },
        {
          "id": 4,
          "text": "Most preferred preliminary investigation is D-dimer"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above scenario is suggestive of pulmonary embolism. ECG shows the&nbsp;<strong>S1Q3T3 sign</strong>&nbsp;(i.e, an S wave in lead I, a Q wave in lead III, and an inverted T wave in lead III) that is relatively <strong>specific</strong> but insensitive.&nbsp;The most common <strong>sign</strong> of pulmonary embolism is <strong>tachypnea.</strong></p>\n<p>Most common <strong>symptom</strong> of pulmonary embolism is <strong>dyspnea</strong>. Most common <strong>ECG abnormality</strong> in pulmonary embolism is <strong>sinus tachycardia</strong>.Most common <strong>preliminary</strong> investigation used is <strong>D</strong>-<strong>dimer</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c65ce46408fd45f9815585362faea2c9x1280x1255.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Chest X Ray signs in pulmonary embolism</h3><p><strong>Westermark's sign:&nbsp;</strong>Focal area of oligemia (decreased vascular markings) distal to the embolism.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1320503c26a8431b903e7e15089c8ed4x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Hampton's hump:&nbsp;</strong>Peripherally placed wedge-shaped or dome-shaped opacity due to infarction of lung tissue.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5faac4b6986f4b6da649d4ca027f99b3x1063x874.JPEG\" alt=\"Pearl Image\"><p><strong>Palla's sign:&nbsp;</strong>Increased size of the right descending pulmonary artery with a sausage-like appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d6849e258104848bfc976a72abaae15x1069x804.JPEG\" alt=\"Pearl Image\"><p><strong>Fleishner sign</strong>: enlarged pulmonary artery.</p>\n<p><strong>Melting sign</strong>:&nbsp;an infarct shows rapid clearing in contrast to pneumonic consolidation.</p>\n<p><strong>McConnell's</strong>&nbsp;<strong>sign</strong> (indirect sign of PE seen in transthoracic echo):&nbsp;<strong>hypokinesis</strong>&nbsp;of the right ventricular free wall with&nbsp;<strong>normal motion</strong>&nbsp;of the right ventricle apex.</p>\n<p><strong>Knuckle&nbsp;</strong>or<strong>&nbsp;sausage&rsquo; sign:&nbsp;</strong>dilatation of the pulmonary artery,&nbsp;proximal to the embolus with collapse or constriction of the distal arteries resulting in an abrupt tapering of these arteries. &nbsp;</p>\n<p>Note - A normal chest X-ray does not rule out pulmonary embolism in a patient with unexplained acute tachypnea or hypoxemia.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e0b61b3332b14758a20b2e04ef0862ed.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7350",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old woman underwent bariatric surgery. On postoperative day 4, she developed pulmonary embolism as confirmed by a CT pulmonary angiography. Her blood pressure was 70/44 mmHg with poor urine output.  IV fluids were administered with dobutamine after which the blood pressure increased to 82/54 mmHg.  What is the most appropriate next step to manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Low molecular weight heparin"
        },
        {
          "id": 2,
          "text": "IVC filter"
        },
        {
          "id": 3,
          "text": "Surgical pulmonary embolectomy"
        },
        {
          "id": 4,
          "text": "Thrombolysis with tPA"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Surgical pulmonary embolectomy</strong> is the most appropriate next step in the management of this patient.&nbsp;</p>\n<p>This patient is suffering from a&nbsp;<strong>massive pulmonary embolism</strong>. In such cases, thrombolytic therapy is given once diagnosis is made using CT pulmonary angiography or bedside ECHO.</p>\n<p>But, since this patient underwent a large open abdominal operation (bariatric surgery), thrombolysis is contraindicated due to the increased risk of life-threatening bleeding. Therefore, <strong>surgical</strong> <strong>embolectomy</strong>&nbsp;must be done. The main pulmonary arteries are incised, and fresh clots are removed.</p>\n<p><strong>Contraindications for thrombolysis:</strong></p>\n<ul>\n<li>Haemorrhagic stroke</li>\n<li>Ischemic stroke in the last 6 months</li>\n<li>CNS tumours</li>\n<li>Major surgery/trauma in the last 3 weeks</li>\n<li>Active bleeding</li>\n<li>Bleeding diathesis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7360",
      "difficulty": "hard"
    },
    {
      "text": "A 42-year-old lady was admitted with unprovoked pulmonary embolism from left distal leg DVT. On admission, her coagulation studies were normal. She was started on unfractionated heparin with the first dose of warfarin on the same day.<div class='question-desc-html'><p><span>After 48 hours of starting warfarin: INR = 3.5</span></p>\n<p><span>Heparin was discontinued, and warfarin was continued at a reduced dose.</span></p>\n<p><span>On day 4:</span></p>\n<ul>\n<li><span>Extensive left leg proximal DVT progressed from the previous scan.</span></li>\n<li><span>INR = 4.2</span></li>\n</ul>\n<p><span>How will you manage her?</span></p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Discontinue warfarin and start long term low molecular weight heparin"
        },
        {
          "id": 2,
          "text": "Reinstitute heparin and continue warfarin"
        },
        {
          "id": 3,
          "text": "Send HIT tests and start argatroban or lepirudin"
        },
        {
          "id": 4,
          "text": "Continue warfarin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This patient had <strong>suboptimal anticoagulation</strong> management. The best approach would be to <strong>reinstitute</strong> <strong>heparin</strong> and continue <strong>warfarin.</strong></p>\n<p>The patient had unprovoked PE from lower limb DVT. She was started on warfarin bridged with heparin initially.</p>\n<p>Warfarin &amp; parenteral anticoagulation need to be overlapped for <strong>at least 5 days</strong>, independent of the INR achieved during these 5 days in patients with acute venous thromboembolism.</p>\n<p>Warfarin inhibits protein C, protein S (which is part of the fibrinolytic pathway) in addition to factors II, VII, IX, X. Protein C has a short half-life (4-6 hours) and thus decreases early. Since protein C is antithrombotic, decreased levels of protein C by warfarin renders the patient hypercoagulable during the first few days of treatment before factor II with a long half-life (36 hours) decreases and protects the patient from thrombosis.</p>\n<p>Thus <strong>warfarin</strong> creates a <strong>prothrombotic</strong> <strong>state</strong> in the first 5 days putting the patient at risk of progression of thrombosis unless a parenteral anticoagulant is given overlapping warfarin for these days.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7363",
      "difficulty": "hard"
    },
    {
      "text": "A 35-year-old lady is admitted with unprovoked pulmonary embolism. On admission, her PT was 13.6 seconds (normal 9.6-13.4 seconds) and aPTT was 62 seconds (normal 28.2-34.6 seconds). She has no history of bleeding. Thrombophilia work up was done and she was found to have a strong lupus anticoagulant. How will you manage the patient’s initial anticoagulation?",
      "choices": [
        {
          "id": 1,
          "text": "Start intravenous unfractionated  heparin with aPTT goal in the upper therapeutic range"
        },
        {
          "id": 2,
          "text": "Start intravenous unfractionated  heparin and monitor with anti Xa tests"
        },
        {
          "id": 3,
          "text": "Start warfarin without heparin bridge because aPTT is already in the therapeutic range"
        },
        {
          "id": 4,
          "text": "Start intravenous argatroban and monitor by aPTT"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">This patient is most probably suffering from <strong>antiphospholipid antibody syndrome</strong> (APS) as her lupus anticoagulant is strongly positive. In such patients, the initial anticoagulation is with <strong>unfractionated heparin</strong> and is monitored by anti-Xa tests.</p>\n<p class=\"p1\">Due to the presence of lupus anticoagulant, the lab measurement of aPTT will show <strong>erroneously prolonged aPTT</strong>. Therefore, even though there is an apparently prolonged aPTT, the patient is at increased risk of thrombosis and not bleeding, and hence patients with APS should be anticoagulated.</p>\n<p class=\"p1\">Anti Xa tests are not influenced by APS. So, the patient can be monitored for the adequacy of anticoagulation with UFH by monitoring anti-Xa.</p>\n<p class=\"p2\">Option A: The patient&rsquo;s aPTT is already prolonged due to lupus anticoagulant, so we cannot monitor the patient with aPTT after starting unfractionated heparin.</p>\n<p class=\"p2\">Option C: Warfarin in the first few days of therapy, causes a decrease in Protein C &amp; S levels, causing a prothrombotic state. Hence, a heparin bridge is necessary for APS which is already a pro-thrombotic state.</p>\n<p class=\"p2\">Option D: Argatroban is a direct thrombin inhibitor used in heparin-induced thrombocytopenia(HIT) to prevent thrombosis and also to increase platelet levels. Therapy is monitored with aPTT.</p>\n<p class=\"p2\">Note: Lupus anticoagulant may function as an inhibitor in vitro by binding to the reagent phospholipid and blocking the phospholipid-dependent reactions of the intrinsic pathway. The net effect is a prolongation of the aPTT.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7365",
      "difficulty": "hard"
    },
    {
      "text": "A 53-year-old woman underwent hip replacement surgery. A week after the surgery, the patient developed swelling of the legs associated with pain on palpation. Her heart rate is 70 beats per min. There is no history of hemoptysis or significant weight loss. There is no previous history of pulmonary embolism. What is the risk of developing pulmonary embolism in the patient based on Well's score?",
      "choices": [
        {
          "id": 1,
          "text": "Low"
        },
        {
          "id": 2,
          "text": "High"
        },
        {
          "id": 3,
          "text": "Moderate"
        },
        {
          "id": 4,
          "text": "Cannot comment without d-dimer values"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The risk of developing pulmonary embolism in this patient is <strong>high</strong> (Option B) according to the three-tiered <strong>Well&rsquo;s clinical risk assessment score.&nbsp;</strong></p>\n<p>Calculation of <strong>Well's score:</strong></p>\n<ul>\n<li>Clinical signs of DVT = 3; &nbsp;- swelling of legs, pain on palpation (Moses sign)</li>\n<li>No alternative diagnosis = 3&nbsp;</li>\n<li>Heart rate is &lt;100 BPM = 0; - 70 BPM</li>\n<li>Surgery in previous 4 weeks = 1.5; - hip replacement surgery 1 week ago&nbsp;</li>\n<li>No previous pulmonary embolism = 0</li>\n<li>No Hemoptysis = 0</li>\n<li>No malignancy = 0; - no significant weight loss&nbsp;</li>\n</ul>\n<p><strong>Total score = 7.5</strong></p>\n<p><strong>Risk stratification:</strong></p>\n<ul>\n<li>High risk = &nbsp;&gt; 6.0</li>\n<li>Moderate risk = &nbsp;2.0 to 6.0</li>\n<li>Low risk = &lt;2.0 (in patients with low risk, to further confirm the risk - pulmonary embolism rule-out criteria (PERC) may be referred)&nbsp;</li>\n</ul>\n<p><strong>Note: </strong>There is no other alternative diagnosis which is more likely in this condition, where there is a clear clinical presentation of a deep vein thrombosis, with the associated risk factors of a recent surgery and immobilization. Hence, 3 points can be added to the score. &nbsp;</p><hr><h3>Related Pearl: Clinical prediction for pulmonary embolism: Well’s, Modified Well’s and Pulmonary Embolism Rule out Criteria (PERC)</h3><table>\n<tbody>\n<tr>\n<td><strong>Signs/symptoms</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Clinical signs of DVT</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Diagnosis other than pulmonary embolism is less likely</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Heart rate &gt;100 bpm</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Immobilization for &gt;3 days or surgery in the last 4 weeks</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Past history of DVT/pulmonary embolism</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Hemoptysis</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Malignancy</td>\n<td>1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Three-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>&lt;2</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>2-6</td>\n</tr>\n<tr>\n<td>High</td>\n<td>&gt;6</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Two-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Modified Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Pulmonary embolism unlikely</td>\n<td>&le;4</td>\n</tr>\n<tr>\n<td>Pulmonary embolism likely</td>\n<td>&gt;4&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>&nbsp;</p>\n<p><strong>Pulmonary embolism rule out criteria (PERC):</strong></p>\n<p>This is a quick OPD/casualty tool to rule out pulmonary embolism in patients with low clinical probability. It comprises <strong>eight clinical variables</strong>. If the patient meets all eight criteria, there is no need for further investigations. The variables include:&nbsp;</p>\n<ol>\n<li aria-level=\"1\">Age &lt;50 years</li>\n<li aria-level=\"1\">Heart rate &lt;100 bpm</li>\n<li aria-level=\"1\">SpO2 &ge;95%</li>\n<li aria-level=\"1\">No unilateral leg swelling</li>\n<li aria-level=\"1\">No hemoptysis</li>\n<li aria-level=\"1\">No recent trauma or surgery</li>\n<li aria-level=\"1\">No history of venous thromboembolism</li>\n<li aria-level=\"1\">No use of hormonal therapy.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0887",
      "difficulty": "medium"
    }
  ]
}